Umifenovir addition gives no significant clinical benefit in COVID-19 treatment: Glenmark study Read more
Beyond highly developed pharma markets! Wild card access to less explored, high entry barrier territories Read more
India, South Africa call for waiver of IP, patents under certain TRIPS provisions for COVID-19 therapeutics Read more
IONTAS and FairJourney Biologics find COVID-19 neutralizing antibodies with picomolar potency Read more
WHO chief lauds India’s assurance to share vaccine production prowess to aid nations fight COVID-19 Read more